Charles Ferté exits AstraZeneca post for parts unknown

Published: 21 April 2021

Charles Ferté, senior director and global project leader of oncology R&D at AstraZeneca, has announced he is leaving the company.

Where Ferté is heading next is currently unclear, with AstraZeneca having provided no statement on his exit at the time of writing. The company has also recently lost cancer R&D chief Jose Baselga, who passed away earlier this year due to Creutzfeldt-Jakob disease.